|
Cardiovascular Pharmacology
Citations 311-320 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 Trial
- Marc S. Sabatine, David A. Morrow, Gilles Montalescot, Mikael Dellborg, Jose L. Leiva-Pons, Matyas Keltai, Sabina A. Murphy, Carolyn H. McCabe, C. Michael Gibson, Christopher P. Cannon, Elliott M. Antman, Eugene Braunwald for the Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators
Circulation published November 15, 2005, doi:10.1161/CIRCULATIONAHA.105.595397
[Abstract]
- Editorials
More Potential for Sildenafil Than Potency
- Felix Mahler and Iris Baumgartner
Circulation 2005;112:2894-2895, doi:10.1161/CIRCULATIONAHA.105.577643
[Full text]
- Heart Failure
Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy: A Pilot Study
- Hideo Izawa, Toyoaki Murohara, Kohzo Nagata, Satoshi Isobe, Hiroyuki Asano, Tetsuya Amano, Sahoko Ichihara, Tomoko Kato, Satoru Ohshima, Yosuke Murase, Shigeo Iino, Koji Obata, Akiko Noda, Kenji Okumura, and Mitsuhiro Yokota
Circulation 2005;112:2940-2945, doi:10.1161/CIRCULATIONAHA.105.571653
[Abstract]
[Full text]
- Editorials
Evolving Therapeutic Strategies for Dystrophinopathies: Potential for Conflict Between Cardiac and Skeletal Needs
- Steven D. Colan
Circulation 2005;112:2756-2758, doi:10.1161/CIRCULATIONAHA.105.577619
[Full text]
- Editorials
Prevention of Restenosis by Systemic Drug Therapy: Back to the Future?
- Albert Schömig, Adnan Kastrati, and Rainer Wessely
Circulation 2005;112:2759-2761, doi:10.1161/CIRCULATIONAHA.105.583484
[Full text]
- Editorials
Type 5 Phosphodiesterase Inhibition: The Focus Shifts to the Heart
- Marc J. Semigran
Circulation 2005;112:2589-2591, doi:10.1161/CIRCULATIONAHA.105.577627
[Full text]
- Heart Failure
Sildenafil Inhibits ß-Adrenergic–Stimulated Cardiac Contractility in Humans
- Barry A. Borlaug, Vojtech Melenovsky, Tricia Marhin, Patricia Fitzgerald, and David A. Kass
Circulation 2005;112:2642-2649, doi:10.1161/CIRCULATIONAHA.105.540500
[Abstract]
[Full text]
- Heart Failure
Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite Sequence: Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III
- Ronnie Willenheimer, Dirk J. van Veldhuisen, Bernard Silke, Erland Erdmann, Ferenc Follath, Henry Krum, Piotr Ponikowski, Allan Skene, Louis van de Ven, Patricia Verkenne, Philippe Lechat on behalf of the CIBIS III Investigators
Circulation 2005;112:2426-2435; published online before print as doi:10.1161/CIRCULATIONAHA.105.582320
[Abstract]
[Full text]
- Hypertension
Angiotensin-Converting Enzyme Inhibitors: A New Mechanism of Action
- Hongmei Peng, Oscar A. Carretero, Nikola Vuljaj, Tang-Dong Liao, Apurva Motivala, Edward L. Peterson, and Nour-Eddine Rhaleb
Circulation 2005;112:2436-2445; published online before print as doi:10.1161/CIRCULATIONAHA.104.528695
[Abstract]
[Full text]
- Hypertension
Enhanced Activity of the Myocardial Na+/H+ Exchanger NHE-1 Contributes to Cardiac Remodeling in Atrial Natriuretic Peptide Receptor–Deficient Mice
- Ana Kilic, Ana Velic, León J. De Windt, Larissa Fabritz, Melanie Voss, Danuta Mitko, Melanie Zwiener, Hideo A. Baba, Martin van Eickels, Eberhard Schlatter, and Michaela Kuhn
Circulation 2005;112:2307-2317, doi:10.1161/CIRCULATIONAHA.105.542209
[Abstract]
[Full text]
|
|
